Blog
New Oral Dose Technology: A Patient-Centric Solution
Improving patient adherence of oral drug products remains a key challenge for drug manufacturers alike. Check out this article and discussion between Pharmaceutical Technology and Adare Pharmaceuticals which discusses a unique approach for industry. 2021 Global Drug...
Rapid Development of API Nano-Formulations from Screening to Production
Improving the solubility of poorly soluble APIs remains one of the biggest challenges for pharmaceutical companies. Not to mention the lengthy and costly drug approval processes, generic incursion, rising development costs and the need for novel adherence strategies,...
Enhancing Drug Bioavailability and Solubility
Enhancing Drug Bioavailability and Solubility Approximately 40% of drugs on the market place and a high percentage of APIs in development are poorly soluble. Optimization of drug solubility and BA of therapeutics stands as one of the top challenges faced by the...
Extended Duration Parenteral Products as Patient Adherence Strategies
Extended Duration Parenteral Products as Patient Adherence Strategies For a number of years, extended-release parenteral formulations have garnered enormous attention due to their effective drug concentrations over extended periods and improve patient compliance...
Customer Experience Marketing for New Products
Customer Experience Marketing for New Products in Emerging Markets Creating the ultimate digital customer experience is a goal that organizations across all types of industries are talking about. Healthcare organizations should be at the top of the list, working to...
Improving Adherence with Patient-Centric Formulations
Improving Adherence with Patient-Centric Formulations The term “patient centered,” “patient centric,” or “patient centricity” has increasingly grown in use in the scientific community in a wide variety of contexts. Generally, patient centric medicines are recognized...